NTRA |
Natera, Inc. |
0 |
4.05% |
|
|
|
|
|
N/A |
0.00% |
37.45% |
9.55% |
---|
TWST |
Twist Bioscience Corporation |
0 |
3.85% |
|
|
|
|
|
N/A |
0.00% |
67.45% |
76.22% |
---|
VCEL |
Vericel Corporation |
0 |
2.79% |
|
|
|
|
|
N/A |
0.00% |
63.85% |
52.75% |
---|
NZYMB.CO |
Novozymes A/S |
|
2.72% |
|
|
|
|
|
|
|
|
|
---|
BPMC |
Blueprint Medicines Corp |
|
2.51% |
|
|
|
|
|
|
|
|
|
---|
VCYT |
Veracyte, Inc. |
0 |
2.51% |
|
|
|
|
|
N/A |
0.00% |
63.06% |
26.55% |
---|
LLY |
Eli Lilly and Company |
0 |
2.35% |
|
|
|
|
|
N/A |
0.00% |
31.61% |
13.40% |
---|
GERN |
Geron Corporation |
0 |
2.08% |
|
|
|
|
|
N/A |
0.00% |
N/A |
25.63% |
---|
BBIO |
BridgeBio Pharma, Inc. |
0 |
2.02% |
|
|
|
|
|
N/A |
0.00% |
55.37% |
15.95% |
---|
AGIO |
Agios Pharmaceuticals, Inc. |
0 |
1.91% |
|
|
|
|
|
N/A |
0.00% |
52.78% |
34.48% |
---|
UTHR |
United Therapeutics Corporation |
0 |
1.84% |
|
|
|
|
|
N/A |
0.00% |
34.70% |
12.84% |
---|
IOVA |
Iovance Biotherapeutics, Inc. |
0 |
1.64% |
|
|
|
|
|
N/A |
0.00% |
257.40% |
29.44% |
---|
SRPT |
Sarepta Therapeutics, Inc. |
0 |
1.60% |
|
|
|
|
|
N/A |
0.00% |
96.53% |
43.40% |
---|
ALNY |
Alnylam Pharmaceuticals, Inc. |
0 |
1.53% |
|
|
|
|
|
N/A |
0.00% |
38.47% |
25.31% |
---|
NEO |
NeoGenomics, Inc. |
0 |
1.48% |
|
|
|
|
|
N/A |
0.00% |
41.22% |
32.82% |
---|
VRTX |
Vertex Pharmaceuticals Incorporated |
0 |
1.45% |
|
|
|
|
|
N/A |
0.00% |
28.18% |
16.47% |
---|
GILD |
Gilead Sciences, Inc. |
0 |
1.44% |
|
|
|
|
|
N/A |
0.00% |
28.40% |
27.15% |
---|
RARE |
Ultragenyx Pharmaceutical Inc. |
0 |
1.41% |
|
|
|
|
|
N/A |
0.00% |
37.87% |
6.21% |
---|
DHR |
Danaher Corporation |
0 |
1.40% |
|
|
|
|
|
N/A |
0.00% |
32.10% |
25.97% |
---|
BEAM |
Beam Therapeutics Inc. |
0 |
1.39% |
|
|
|
|
|
N/A |
0.00% |
70.83% |
32.66% |
---|
DD |
DuPont de Nemours, Inc. |
0 |
1.39% |
|
|
|
|
|
N/A |
0.00% |
27.75% |
22.98% |
---|
BMY |
Bristol-Myers Squibb Company |
0 |
1.36% |
|
|
|
|
|
N/A |
0.00% |
32.44% |
30.34% |
---|
FOLD |
Amicus Therapeutics, Inc. |
0 |
1.35% |
|
|
|
|
|
N/A |
0.00% |
121.84% |
80.10% |
---|
NOVN.SW |
Novartis AG |
|
1.33% |
|
|
|
|
|
|
|
|
|
---|
LH |
Laboratory Corporation of America Holdin... |
0 |
1.29% |
|
|
|
|
|
N/A |
0.00% |
22.43% |
19.90% |
---|
AMGN |
Amgen Inc. |
0 |
1.29% |
|
|
|
|
|
N/A |
0.00% |
23.87% |
12.44% |
---|
QGEN |
Qiagen N.V. |
0 |
1.28% |
|
|
|
|
|
N/A |
0.00% |
31.08% |
27.53% |
---|
TSN |
Tyson Foods, Inc. |
0 |
1.27% |
|
|
|
|
|
N/A |
0.00% |
24.12% |
18.42% |
---|
CTVA |
Corteva, Inc. |
0 |
1.24% |
|
|
|
|
|
N/A |
0.00% |
28.46% |
25.84% |
---|
BNTX |
BioNTech SE |
0 |
1.24% |
|
|
|
|
|
N/A |
0.00% |
45.27% |
20.94% |
---|
ZTS |
Zoetis Inc. |
0 |
1.21% |
|
|
|
|
|
N/A |
0.00% |
26.74% |
19.59% |
---|
TMO |
Thermo Fisher Scientific Inc. |
0 |
1.20% |
|
|
|
|
|
N/A |
0.00% |
31.98% |
31.85% |
---|
IONS |
Ionis Pharmaceuticals, Inc. |
0 |
1.19% |
|
|
|
|
|
N/A |
0.00% |
45.82% |
34.32% |
---|
STOK |
Stoke Therapeutics, Inc. |
0 |
1.18% |
|
|
|
|
|
N/A |
0.00% |
51.22% |
9.82% |
---|
JNJ |
Johnson & Johnson |
0 |
1.17% |
|
|
|
|
|
N/A |
0.00% |
20.15% |
27.11% |
---|
RGEN |
Repligen Corporation |
0 |
1.16% |
|
|
|
|
|
N/A |
0.00% |
42.09% |
8.56% |
---|
SYENS BB |
Syensqo Sa |
|
1.16% |
|
|
|
|
|
|
|
|
|
---|
REGN |
Regeneron Pharmaceuticals, Inc. |
0 |
1.14% |
|
|
|
|
|
N/A |
0.00% |
33.37% |
26.80% |
---|
AZN |
AstraZeneca PLC |
0 |
1.12% |
|
|
|
|
|
N/A |
0.00% |
25.35% |
23.55% |
---|
MRK |
Merck & Co., Inc. |
0 |
1.12% |
|
|
|
|
|
N/A |
0.00% |
33.23% |
35.51% |
---|
EXAS |
Exact Sciences Corporation |
0 |
1.12% |
|
|
|
|
|
N/A |
0.00% |
47.28% |
30.15% |
---|
TECH |
Bio-Techne Corporation |
0 |
1.10% |
|
|
|
|
|
N/A |
0.00% |
44.45% |
44.19% |
---|
ILMN |
Illumina, Inc. |
0 |
1.10% |
|
|
|
|
|
N/A |
0.00% |
44.93% |
23.20% |
---|
DAR |
Darling Ingredients Inc. |
0 |
1.08% |
|
|
|
|
|
N/A |
0.00% |
57.04% |
40.53% |
---|
CRSP |
CRISPR Therapeutics AG |
0 |
1.07% |
|
|
|
|
|
N/A |
0.00% |
67.79% |
55.84% |
---|
ARCT |
Arcturus Therapeutics Holdings Inc. |
0 |
1.00% |
|
|
|
|
|
N/A |
0.00% |
190.39% |
101.10% |
---|
BIO |
Bio-Rad Laboratories, Inc. |
0 |
0.98% |
|
|
|
|
|
N/A |
0.00% |
35.84% |
17.27% |
---|
MYGN |
Myriad Genetics, Inc. |
0 |
0.96% |
|
|
|
|
|
N/A |
0.00% |
55.82% |
20.67% |
---|
DOW |
Dow Inc. |
0 |
0.96% |
|
|
|
|
|
N/A |
0.00% |
50.91% |
48.56% |
---|
4502.T |
Takeda Pharmaceutical Co Ltd |
|
0.94% |
|
|
|
|
|
|
|
|
|
---|
ARGX |
argenx SE |
0 |
0.92% |
|
|
|
|
|
N/A |
0.00% |
29.76% |
26.04% |
---|
GMAB |
Genmab A/S |
0 |
0.91% |
|
|
|
|
|
N/A |
0.00% |
216.39% |
12.58% |
---|
ARWR |
Arrowhead Pharmaceuticals, Inc. |
0 |
0.90% |
|
|
|
|
|
N/A |
0.00% |
49.07% |
16.24% |
---|
PFE |
Pfizer Inc. |
0 |
0.86% |
|
|
|
|
|
N/A |
0.00% |
25.63% |
13.33% |
---|
FATE |
Fate Therapeutics, Inc. |
0 |
0.83% |
|
|
|
|
|
N/A |
0.00% |
337.67% |
79.47% |
---|
ADM |
Archer-Daniels-Midland Company |
0 |
0.83% |
|
|
|
|
|
N/A |
0.00% |
30.04% |
29.57% |
---|
SDGR |
Schrödinger, Inc. |
0 |
0.82% |
|
|
|
|
|
N/A |
0.00% |
57.28% |
17.70% |
---|
BMRN |
BioMarin Pharmaceutical Inc. |
0 |
0.80% |
|
|
|
|
|
N/A |
0.00% |
39.06% |
42.65% |
---|
NTR |
Nutrien Ltd. |
0 |
0.80% |
|
|
|
|
|
N/A |
0.00% |
25.91% |
18.65% |
---|
ACLX |
Arcellx, Inc. |
0 |
0.72% |
|
|
|
|
|
N/A |
0.00% |
45.24% |
15.48% |
---|
BAYN.DE |
Bayer AG |
|
0.69% |
|
|
|
|
|
|
|
|
|
---|
RVMD |
Revolution Medicines, Inc. |
0 |
0.68% |
|
|
|
|
|
N/A |
0.00% |
44.75% |
30.37% |
---|
BHVN |
Biohaven Pharmaceutical Holding Company ... |
0 |
0.68% |
|
|
|
|
|
N/A |
0.00% |
148.65% |
88.53% |
---|
FMC |
FMC Corporation |
0 |
0.67% |
|
|
|
|
|
N/A |
0.00% |
39.75% |
20.65% |
---|
BIIB |
Biogen Inc. |
0 |
0.64% |
|
|
|
|
|
N/A |
0.00% |
33.43% |
16.77% |
---|
LNZ AV |
Lenzing AG |
|
0.64% |
|
|
|
|
|
|
|
|
|
---|
NUF.AX |
Nufarm Ltd/Australia |
|
0.59% |
|
|
|
|
|
|
|
|
|
---|
TEM |
Tempus Ai Inc |
|
0.58% |
|
|
|
|
|
|
|
|
|
---|
VERV |
Verve Therapeutics Inc |
|
0.58% |
|
|
|
|
|
|
|
|
|
---|
DNA |
Ginkgo Bioworks Holdings, Inc. |
0 |
0.57% |
|
|
|
|
|
N/A |
0.00% |
92.54% |
17.95% |
---|
GPCR |
Structure Therapeutics Inc. |
0 |
0.56% |
|
|
|
|
|
N/A |
0.00% |
74.59% |
55.31% |
---|
PACB |
Pacific Biosciences of California, Inc. |
0 |
0.55% |
|
|
|
|
|
N/A |
0.00% |
539.52% |
58.52% |
---|
RGNX |
REGENXBIO Inc. |
0 |
0.54% |
|
|
|
|
|
N/A |
0.00% |
113.88% |
21.92% |
---|
ALLO |
Allogene Therapeutics, Inc. |
0 |
0.53% |
|
|
|
|
|
N/A |
0.00% |
553.67% |
52.12% |
---|
ONT.L |
Oxford Nanopore Technologies |
|
0.49% |
|
|
|
|
|
|
|
|
|
---|
GNS.L |
Genus Plc |
|
0.49% |
|
|
|
|
|
|
|
|
|
---|
CRBU |
Caribou Biosciences, Inc. |
0 |
0.47% |
|
|
|
|
|
N/A |
0.00% |
202.46% |
26.70% |
---|
CVAC |
CureVac N.V. |
0 |
0.45% |
|
|
|
|
|
N/A |
0.00% |
121.13% |
16.20% |
---|
TXG |
10x Genomics, Inc. |
0 |
0.45% |
|
|
|
|
|
N/A |
0.00% |
73.78% |
15.78% |
---|
GPRE |
Green Plains Inc. |
0 |
0.43% |
|
|
|
|
|
N/A |
0.00% |
73.26% |
16.08% |
---|
NTLA |
Intellia Therapeutics, Inc. |
0 |
0.42% |
|
|
|
|
|
N/A |
0.00% |
93.78% |
49.70% |
---|
4974.T |
Takara Bio Inc |
|
0.41% |
|
|
|
|
|
|
|
|
|
---|
BYND |
Beyond Meat, Inc. |
0 |
0.38% |
|
|
|
|
|
N/A |
0.00% |
109.07% |
36.31% |
---|
ORGN |
Origin Materials, Inc. |
0 |
0.37% |
|
|
|
|
|
N/A |
0.00% |
271.37% |
49.25% |
---|
MRNA |
Moderna, Inc. |
0 |
0.35% |
|
|
|
|
|
N/A |
0.00% |
79.03% |
45.63% |
---|
SOLB BB |
Solvay SA |
|
0.35% |
|
|
|
|
|
|
|
|
|
---|
ABSI |
Absci Corporation |
0 |
0.34% |
|
|
|
|
|
N/A |
0.00% |
77.28% |
40.03% |
---|
VBK.DE |
Verbio AG |
|
0.27% |
|
|
|
|
|
|
|
|
|
---|
EDIT |
Editas Medicine, Inc. |
0 |
0.25% |
|
|
|
|
|
N/A |
0.00% |
275.07% |
38.43% |
---|
SANA |
Sana Biotechnology, Inc. |
0 |
0.23% |
|
|
|
|
|
N/A |
0.00% |
270.95% |
21.03% |
---|